Efficacy of naproxen alone or with cinnarizine compared to placebo as an abortive treatment of vestibular migraine: a randomised placebo controlled, double blind study - VESMINACI

DrJayantee Kalita0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•The patients with migraine having dizziness will be evaluated for Vestibular Migraine. The moderate to severe VM patients will be included from Neurology outpatient service, SGPGI during the year 2023 to 2024. The diagnosis of VM will be based on an international headache society criteria for VM.

•The patient with existing hearing problem, neurological findings, structural abnormality on
•CT/ MRI, deafness, vestibular transient ischemic attack, hypertension (BP >160/100 mm Hg),
•coronary artery disease, hepatic or kidney failure, chronic obstructive airway disease,
•malignancy, systemic diseases, vasculitis, on cancer chemotherapy, immune suppressants,
•migraine prophylactic treatment, pregnancy, lactation, on oral contraceptive drugs, alcohol
•(taking >14 drinks per week) or any other addiction, children < 18 years or elderly > 65 years
•and those with history of allergy to naproxen or cinnarizine and not willing to give consent

发起方

DrJayantee Kalita